Drugs / ARTEMIFONE
ARTEMIFONE
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00936767 | Oct 2010 | Plasmodium falciparum malaria | University of Oxford | Withdrawn | No outcome recorded |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ARTEMIFONE | ChEMBL registry synonym — accepted as the source's own label CHEMBL516268 ↗ |
| Known as | Artemisone | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00936767 ↗ |
| Known as | BAY 44-9585 | ChEMBL registry synonym — accepted as the source's own label CHEMBL516268 ↗ |
| Modality | Small molecule | — CHEMBL516268 ↗ |
| Route | Oral | “comparing the efficacy of oral artemisone with oral artesunate” NCT00936767 ↗ |